An explainer on compounded semaglutide and tirzepatide care after the shortages ended, noting FDA reports of dosing errors from multidose vials.
Recap by typeshit. Full story at The Commercial Appeal.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
BioPharma Dive reports the recall adds to safety worries about knockoff weight loss drugs, which stay popular despite FDA warnings and pressure from Lilly and Novo.
The actress has spoken out with a warning about Ozempic. Only a short link is given, with no details on what she said.
Trials showed low rates, while FAERS and EudraVigilance logged a wider range of events. The Warwick-linked authors call for standardized reporting and close monitoring.
Dr. Alo says the heart benefit isn't just a byproduct of weight loss. That's his view, posted on social, not a new study.
A short teaser comparing how well people tolerate the two main GLP-1 ingredients, with the full breakdown behind the link.
Loading…